Routine share withholding; mechanical by default.
Traded Feb 13, 2026 · Filed Feb 14, 2026
Roivant Sciences's Reporting person sold $5.96M of Roivant Sciences shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$5,962,500
Shares × reported transaction price
7 days after results of Feb 6, 2026, 48 days before results of Apr 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.3% | +0.7% | +3.7% |
| 30 days | +2.6% | −3.4% | +6.0% |
| 90 days | +5.4% | +8.2% | −2.8% |
| 180 days | +33.8% | +13.2% | +20.6% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.